Company at a Glance
Our strategy, priorities, structure, research and development, leadership, and awards and recognition, as well as our commitment to healthcare reform, policy dialogue and responsible business practices.
In this section
- Our Strategy and Priorities
- At Novartis, we are united by a single purpose to reimagine medicine to improve and extend people’s lives.
- Our Country Leadership Team
- Novartis US is led by the Country Leadership Team (CLT) which includes the US Division CEOs and Country Heads of the key functions responsible for identifying cross-divisional collaboration synergies and driving alignment on corporate matters.
- Our Products and Reach
- Novartis develops and produces medicines to address patient needs in disease areas where our experience and knowledge have the greatest potential to improve patient outcomes.
- Research and Development
- In 2019, Novartis invested USD 3.9 billion in US-based research and development (R&D), representing more than 41% of our global R&D spend of USD 9.4 billion.
- Value and Pricing
- At Novartis, we are pushing the boundaries of science to reimagine medicine and bring the benefits of transformative innovation to patients everywhere.
- Responsible Business Practices
- At Novartis, we are committed to responsible business practices across our company.
- Shaping our Healthcare Environment
- Novartis provides healthcare solutions that address the evolving needs of patients and societies worldwide.
- Awards & Recognition
- Novartis is honored to receive numerous awards for our progress in research and development, our working environment and our corporate responsibility activities.